Dörken B - Search Results

1

CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.

Pezzutto A, Dörken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA. Pezzutto A, et al. Among authors: dorken b. J Immunol. 1987 May 1;138(9):2793-9. J Immunol. 1987. PMID: 2437199

2

Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.

Pezzutto A, Dörken B, Moldenhauer G, Clark EA. Pezzutto A, et al. Among authors: dorken b. J Immunol. 1987 Jan 1;138(1):98-103. J Immunol. 1987. PMID: 3097151

3

Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin.

Pezzutto A, Rabinovitch PS, Dörken B, Moldenhauer G, Clark EA. Pezzutto A, et al. Among authors: dorken b. J Immunol. 1988 Mar 15;140(6):1791-5. J Immunol. 1988. PMID: 3257985

4

Complement-mediated cytolysis: quantification of B cell surface antigen molecules and role of cell cycle.

Kiesel S, Moldenhauer G, Pezzutto A, Haas R, Dörken B. Kiesel S, et al. Among authors: dorken b. Immunol Lett. 1988 Mar;17(3):241-7. doi: 10.1016/0165-2478(88)90036-3. Immunol Lett. 1988. PMID: 2453455

5

HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

Dörken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM. Dörken B, et al. J Immunol. 1986 Jun 15;136(12):4470-9. J Immunol. 1986. PMID: 3086431

6

The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein.

Schwartz-Albiez R, Dörken B, Hofmann W, Moldenhauer G. Schwartz-Albiez R, et al. Among authors: dorken b. J Immunol. 1988 Feb 1;140(3):905-14. J Immunol. 1988. PMID: 3257508

7

Functional evaluation of CD19- and CD22-negative variants of B-lymphoid cell lines.

Kiesel S, Pezzutto A, Haas R, Moldenhauer G, Dörken B. Kiesel S, et al. Among authors: dorken b. Immunology. 1988 Jul;64(3):445-50. Immunology. 1988. PMID: 3261711 Free PMC article.

8

CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.

Schwartz-Albiez R, Dörken B, Monner DA, Moldenhauer G. Schwartz-Albiez R, et al. Among authors: dorken b. Int Immunol. 1991 Jul;3(7):623-33. doi: 10.1093/intimm/3.7.623. Int Immunol. 1991. PMID: 1716973

9

Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.

Schwarting R, Castello R, Moldenhauer G, Pezzutto A, von Hoegen I, Ludwig WD, Parnes JR, Dörken B. Schwarting R, et al. Among authors: dorken b. Am J Hematol. 1992 Nov;41(3):151-8. doi: 10.1002/ajh.2830410303. Am J Hematol. 1992. PMID: 1384316

10

Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxins.

May RD, Vitetta ES, Moldenhauer G, Dörken B. May RD, et al. Among authors: dorken b. Cancer Drug Deliv. 1986 Fall;3(4):261-72. doi: 10.1089/cdd.1986.3.261. Cancer Drug Deliv. 1986. PMID: 2436739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters